Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
January 27th, 2019
14.6K views
The Trypanosoma cruzi agent of Chagas disease produces long-lasting asymptomatic infections that abruptly develop into clinically recognized pathology. The following research protocol describes a short-run family-based epidemiological study to unravel the T. cruzi infection transmitted sexually from parent to progeny.
Overview
This study investigates the sexual transmission of Trypanosoma cruzi, the causative agent of Chagas disease, through a family-based epidemiological approach. It highlights the potential for long-lasting asymptomatic infections to develop into clinically recognized pathology.
Key Study Components
Area of Science
- Neuroscience
- Infectious Diseases
- Epidemiology
Background
- Trypanosoma cruzi is responsible for Chagas disease.
- Infections can remain asymptomatic for extended periods.
- Clinical symptoms may emerge suddenly.
- Previous findings suggest possible sexual transmission routes.
Purpose of Study
- To explore the sexual transmission of T. cruzi from parents to offspring.
- To recruit families with clinical symptoms of acute Chagas disease.
- To validate molecular assays for detecting T. cruzi.
Methods Used
- Health care delivery over five years.
- Collection of venous blood samples from family participants.
- Storage of blood aliquots at controlled temperatures.
- Isolation of T. cruzi from blood samples for analysis.
Main Results
- Identification of T. cruzi in blood samples from acute Chagas disease cases.
- Evidence supporting the hypothesis of sexual transmission.
- Successful validation of molecular assays.
- Data collection over multiple time points enhances reliability.
Conclusions
- The study provides insights into the transmission dynamics of T. cruzi.
- Findings may influence future epidemiological studies.
- Further research is needed to fully understand transmission mechanisms.
Frequently Asked Questions
What is Chagas disease?
Chagas disease is a tropical parasitic disease caused by Trypanosoma cruzi.
How is T. cruzi transmitted?
T. cruzi can be transmitted through insect bites, blood transfusions, and potentially sexually.
What are the symptoms of Chagas disease?
Symptoms can include fever, fatigue, and swelling at the infection site, but many remain asymptomatic.
Why is this study important?
It explores a potential transmission route that could impact public health strategies.
What methods were used in this research?
The study involved blood sample collection and molecular assays to detect T. cruzi.
How long did the study last?
The study was conducted over a period of five years.
What are the implications of the findings?
The findings may lead to better understanding and management of Chagas disease transmission.
Executive Industry Relevance
This study provides evidence for sexual transmission of Trypanosoma cruzi, a neglected tropical pathogen, through detection of parasite DNA in gametes and vertical transmission in animal models. The findings highlight a non-vector-borne transmission route that complicates disease control and necessitates expanded diagnostic screening in blood and reproductive tissues. Understanding sexual transmission mechanisms supports target validation for interventions aimed at blocking gamete-mediated pathogen spread in endemic populations.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Detects T. cruzi nuclear DNA in haploid gametes, enabling interrogation of sexual transmission as a therapeutic hypothesis.
- Operational Value: Uses nested PCR and immunofluorescence assays to validate parasite presence in semen and vaginal secretions.
- Predictive Value: Demonstrates vertical transmission in murine models, supporting preclinical evaluation of transmission-blocking candidates.
Assay Development & Screening Readiness
- Scientific Value: Establishes nDNA-PCR as a quantitative method for detecting low-abundance parasite DNA in blood and reproductive fluids.
- Operational Value: Enables standardization of sample processing via density gradient centrifugation and DNA extraction from spermatozoa.
- Screening Application: Supports development of dual-target assays combining nucleic acid and serological detection to identify immune-tolerant infections.
Translational Biomarker & Preclinical Modeling
- Scientific Value: Identifies immune tolerance in progeny despite parasite presence, modeled in chickens inoculated embryonically with T. cruzi.
- Operational Value: Uses murine breeding pairs to demonstrate mate-to-mate and vertical transmission, providing a scalable preclinical system.
- Translational Relevance: Links parasite detection in vas deferens, epididymis, and uterine tubes to clinical samples from human subjects.
Pipeline & Workflow Integration
The method integrates into discovery workflows by enabling early detection of sexually transmissible pathogens in biological samples prior to lead identification efforts.
- Discovery Biology: Supports hypothesis testing of sexual transmission routes through longitudinal sampling of blood and gametes over one-year intervals.
- Assay Development: Generates reproducible quantitative outputs via nDNA-PCR and ELISA, facilitating cross-laboratory validation.
- Analytics: Measures parasite DNA load and antibody titers to distinguish active infection from immune tolerance, informing risk assessment.
- Translational Research: Connects animal model findings to human family studies, enabling extrapolation of transmission dynamics.
- Enterprise Reuse: Establishes a modular workflow for sampling reproductive tissues applicable to other sexually transmissible pathogens.
Operational & Enterprise Impact
- Scientific Value: Provides mechanistic insight into pathogen persistence and transmission independent of vector exposure.
- Operational Value: Establishes standardized protocols for semen and vaginal secretion processing, enabling biobanking and longitudinal tracking.
- Strategic Value: Informs go/no-go decisions for therapeutic candidates by identifying transmission reservoirs in reproductive compartments.
- Portfolio Impact: Supports risk-adjusted prioritization of interventions targeting gamete-mediated pathogen spread in endemic regions.
Implementation Considerations
- Requires expertise in molecular parasitology, including PCR optimization and immunofluorescence microscopy.
- Dependent on access to thermocyclers, gel electrophoresis systems, and fluorescence microscopes with UV excitation.
- Necessitates standardized handling of biological fluids to prevent degradation of parasite DNA and antigen integrity.
- Involves ethical and regulatory considerations for collecting human semen and vaginal samples in endemic populations.
- Limited by low parasite burden in gametes, requiring high-sensitivity detection methods to avoid false negatives.
Biopharma FAQs
Why does nDNA-PCR detection in spermatozoa matter for target validation?
Detection of T. cruzi nuclear DNA in spermatozoa confirms the parasite's presence in male gametes, supporting the hypothesis of sexual transmission. This finding enables target validation of pathways involved in gamete invasion and persistence. It provides a mechanistic basis for developing interventions that block parasite transmission via semen.
How does isolation of T. cruzi from blood aliquots support assay development?
Isolating T. cruzi from blood samples allows for the production of parasite antigens used to validate molecular and immunological assays. This step ensures assay specificity by confirming reactivity with homologous parasite strains. It enables standardization of positive controls across nDNA-PCR, ELISA, and immunofluorescence platforms.
What do quantitative dependent variable measurements enable in transmission studies?
Quantitative measurements of parasite DNA load via nDNA-PCR and antibody titers via ELISA allow comparison of infection levels across sample types and time points. These outputs help distinguish active infection from immune tolerance, particularly in progeny with detectable parasites but absent antibodies. Such data support statistical modeling of transmission efficiency and vertical transfer rates.
Why do replication requirements matter for cross-functional collaboration?
Collecting blood, semen, and vaginal samples at three time points one year apart ensures reproducibility and strengthens evidence for sexual transmission. Replication across family members and generations validates findings beyond individual variability. This longitudinal design enables epidemiologists, molecular biologists, and preclinical scientists to align on consistent transmission metrics.
What statistical analysis capabilities are required before implementing this workflow?
Implementation requires statistical comparison of nDNA-PCR positivity rates between exposed and naive mates, as well as vertical transmission frequencies in progeny. Analysis must account for discordance between parasite detection and serological response, particularly in immune-tolerant individuals. These capabilities are essential to assess transmission significance and guide go/no-go decisions for intervention strategies.
Chapters in this video
0:01
Title
1:17
Growth of Parasites
2:53
DNA Extraction and PCR Analysis
4:22
Southern Hybridization
4:58
Immunological Assays - Immunofluorescence
6:22
Immunological Assays - ELISA
7:16
Assessment of the Immune Tolerance
8:22
Infection of Mice with the Trypanosoma cruzi Chagas Patient's Semen Ejaculates
9:00
Representative Results
11:54
Conclusion
